Podcast: Critical Outcome Technologies CEO Wayne Danter on new ways to develop drugs

Critical Outcome Technologies Inc. (CVE:COT) uses machine learning and computer science to create clinical and pre-clinical stage drugs with a focus on oncology. Listen to the podcast interview with Dr. Wayne Danter:http://wpmedia.business.financialpost.com/2016/05/dr-wayne-danter-critical-outcome-tech-042616-podcast.mp3  James West: Wayne, thanks for joining us today. Dr. Wayne Danter: Oh, thank you for having me. James West: Wayne, let’s start with an overview of the value proposition for investors in Critical Outcome Technologies Inc. Dr. Wayne Danter: Sure. Critical Outcome Technologies is a clinical stage drug discovery and pre-clinical development company built around a computational platform. So what we do differently is to do much of the discovery work in computer simulations. That allows us to be very cost-effective in terms of identifying high probability drug candidates that we want to take forward.  So for example,…


Link to Full Article: Podcast: Critical Outcome Technologies CEO Wayne Danter on new ways to develop drugs

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!